Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

NCT00092521 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5759

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer
Genital Warts

Interventions

BIOLOGICAL: V501
BIOLOGICAL: Comparator: Placebo
BIOLOGICAL: Human Papillomavirus (HPV) 16 Monovalent

Sponsor

Merck Sharp & Dohme LLC